RIGL
NASDAQ · Biotechnology
Rigel Pharmaceuticals Inc
$26.04
-0.20 (-0.76%)
Open$26.24
Previous Close$26.24
Day High$26.96
Day Low$26.00
52W High$52.24
52W Low$16.88
Volume—
Avg Volume371.4K
Market Cap484.75M
P/E Ratio1.32
EPS$18.62
SectorBiotechnology
Analyst Ratings
Buy
12 analysts
Price Target
+107.8% upside
Current
$26.04
$26.04
Target
$54.10
$54.10
$39.68
$54.10 avg
$74.39
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 290.78M | 215.74M | 385.25M |
| Net Income | 362.66M | 242.17M | -63,461,041 |
| Profit Margin | 124.7% | 118.5% | -16.5% |
| EBITDA | 126.36M | 89.06M | -108,813,206 |
| Free Cash Flow | — | — | -71,858,369 |
| Rev Growth | +34.8% | +34.8% | +12.7% |
| Debt/Equity | 0.13 | 0.13 | 0.83 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |